MedCity News April 13, 2021
Stephanie Baum

Peter Meath, Co-Head of Healthcare and Life Sciences for Middle Market Commercial Banking at J.P. Morgan, is bullish that the momentum will continue, particularly with investment trends focused on pain points amplified by the Covid-19 pandemic, from diagnostics development to supply chain management.

With the public health crisis causing widespread disruption to our lives, we were bracing for a downturn in investment last year that never came. Instead, the markets rallied around healthcare and life science companies and so did investors. In fact, venture capital investment in life sciences soared to a record high in the third quarter of last year. So what’s in store for 2021?  Peter Meath, Co-Head of Healthcare and Life Sciences for Middle Market Commercial Banking...

 
Topics: Biotechnology, Healthcare System, Investments, Pharma, Pharma / Biotech, Public Health, Trends
Healthcare Private Equity and COVID-19: Five Key Trends and Considerations in Acquisitions

Today's Sponsors

Curation Health
Philips
HealthITq

Today's Sponsors

Holon
ClearDATA

Today's Sponsor

Qure4u

2021-04-13T22:48:12-04:00